"Das Klinikum Wels-Grieskirchen ist als größtes Ordensspital Österreichs eine Institution der Kongregation der Barmherzigen Schwestern vom heiligen Kreuz und der Franziskanerinnen von Vöcklabruck."

During the past decade, Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator, "AOP Orphan Pharmaceuticals AG" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV" are "Breast Cancer" (2 trials), "Breast Carcinoma" (1 trials), "Breast Tumor" (1 trials), "Chemotherapy-induced Nausea and Vomiting" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV" in a lesser frequency.

Most popular intervention types in "Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Carboplatin" (1 trials), "Cyclophosphamide" (1 trials), "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials) and "Dronabinol in Oral Dosage Form" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Wels-Grieskirchen Abteilung für Innere Medizin IV, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".